1.
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised,...
by Sax, Paul E, Dr Prof
The Lancet (British edition), 2015, Vol.385 (9987), p.2606-2615
2.
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING...
by Cahn, Pedro, Dr
The Lancet (British edition), 2013, Vol.382 (9893), p.700-708
3.
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected...
by Molina, Jean-Michel, Prof
The Lancet (British edition), 2008, Vol.372 (9639), p.646-655
Filter electronic articles 3 Hits
Remove Filters
- Journal Title
- The Lancet
- Human Immunodeficiency Virus (3)
- Humans
- Hiv Infections - Drug Therapy
- Female (3)
- Drug Therapy (3)
- Hiv (3)
- Medicine, General & Internal (2)
- Middle Aged (2)
- Treatment Outcome (2)
- Life Sciences & Biomedicine (2)
- Science & Technology (2)
- Antiretroviral Drugs (2)
- Double-Blind Method (2)
- Drug Administration Schedule (2)
- General & Internal Medicine (2)
- Hiv Infection (2)
- Hiv-1 (2)
- less ...